Treatment of Diffuse Large B-Cell Lymphoma

We are inviting Haematologists / Haematological-Oncologists / Medical Oncologists to participate in a group workshop on a virtual platform with audio capabilities, which will last for 120 minutes. The purpose of this research is to understand a decision-making process around the treatment and management of DLBCL (diffuse large B-cell lymphoma) in patients. To apply for this important study, please log in or sign up below.

  • Location: Nationwide, UK
  • Date: 8th and 10th of June
  • Time: Several time slots available, to be agreed over the phone
  • Duration: 2 hours
  • Incentive: £240
  • Availability: 12 slots available